<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04578366</url>
  </required_header>
  <id_info>
    <org_study_id>RE-MS-OMPT/Spring19/032 Adnan</org_study_id>
    <nct_id>NCT04578366</nct_id>
  </id_info>
  <brief_title>Extracorporeal Shockwave Therapy in Long-term Functional Outcomes of Shoulder Adhesive Capsulitis</brief_title>
  <official_title>Effects Of Extracorporeal Shockwave Therapy in Long-term Functional Outcomes of Shoulder Adhesive Capsulitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Riphah International University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Riphah International University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adhesive capsulitis refers to the occurrence of pain and a gradual decline in the range of&#xD;
      motion (ROM) due to slow increases in synovial hypertrophy and the adhesion between the&#xD;
      synovial membrane and articular surface. It leads to the loss of flexibility and difficulties&#xD;
      with the activities of daily living (ADLs) due to chronic inflammation accompanied by&#xD;
      intra-articular fibrosis. The real cause of this syndrome is unknown but there are some&#xD;
      predisposing factors involved such as synovial cell hyperplasia, fibrosis of the capsule due&#xD;
      to cytokines or other inflammatory factors. In the current study investigator will compare&#xD;
      the effects of Extracorporeal Shockwave Therapy (ESWT) along with conventional therapy to&#xD;
      treat the adhesive capsulitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a Randomized Controlled Trail conducted at Horizon hospital, Lahore. The&#xD;
      study will be completed within the time duration of Six months. Consecutive sampling&#xD;
      technique will be used to collect the data. The sample size of 44 patients will be taken in&#xD;
      this study to find the effects of ESWT on pain, ROM, functional mobility. Patient will be&#xD;
      divided into two groups. Group A will be treated with ESWT with conventional therapy and&#xD;
      Group B will be treated with conventional therapy. Constant Shoulder Score (CSS) and the&#xD;
      Oxford Shoulder Score (OSS) tools will be used to measure the outcomes of the study.&#xD;
&#xD;
      One session of treatment per week for four weeks will be given. Pretest, posttest at 4th week&#xD;
      and followup of 24th weeks will be evaluated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 15, 2019</start_date>
  <completion_date type="Actual">June 28, 2020</completion_date>
  <primary_completion_date type="Actual">June 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Constant Shoulder Score (CSS)</measure>
    <time_frame>8 months</time_frame>
    <description>The functional outcome of shoulder. Grading the Constant Shoulder Score (Difference between normal and Abnormal Side)&#xD;
&gt;30 Poor 21-30 Fair 11-20 Good &lt;11 Excellent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Range of motion</measure>
    <time_frame>8 months</time_frame>
    <description>Oxford Shoulder Score (OSS), increasing score shows improvement, decrease in scores shows deterioration.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>NPRS-numeric pain rating scale</measure>
    <time_frame>8 months</time_frame>
    <description>This scale ranges 0-10, 10 means severe pain while 0 means no pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Adhesive Capsulitis of Shoulder</condition>
  <arm_group>
    <arm_group_label>Shockwavetherapy Group/Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ESWT along with conventional therapy ESWT + hot pack(10min), ultrasound (5min), mobilizations, stretching, pendulum exercises, isometrics of shoulder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional therapy hot pack(10min), ultrasound (5min), mobilizations, stretching, pendulum exercises, isometrics of shoulder</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extracorporeal Shockwave Therapy</intervention_name>
    <description>ESWT along with conventional therapy ESWT + hot pack(10min), ultrasound (5min), mobilizations, stretching, pendulum exercises, isometrics of shoulder</description>
    <arm_group_label>Shockwavetherapy Group/Experimental group</arm_group_label>
    <other_name>Experimental Group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional Treatment</intervention_name>
    <description>hot pack(10min), ultrasound (5min), mobilizations, stretching, pendulum exercises, isometrics of shoulder</description>
    <arm_group_label>Conventional Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Relapsed or episode of pain score ≥5 at assessment with a past history of pain for at&#xD;
             least 2 months.&#xD;
&#xD;
          -  ROM restriction (&gt;75% ROM loss in ≥2 directions including abduction, flexion and&#xD;
             external rotation)&#xD;
&#xD;
          -  No treatment other than analgesics with unresponsive ROM restriction for the past&#xD;
             2months.&#xD;
&#xD;
          -  Unwilling or waiting and did not undergo joint injection.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  bilateral shoulder involvement&#xD;
&#xD;
          -  History of previous surgery on the shoulder&#xD;
&#xD;
          -  Shoulder fracture&#xD;
&#xD;
          -  Cancer&#xD;
&#xD;
          -  Glenohumeral or Acromioclavicular arthritis&#xD;
&#xD;
          -  Inflammatory disorders&#xD;
&#xD;
          -  Bleeding disorders&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Presence of severe osteoporosis&#xD;
&#xD;
          -  Pulmonary diseases&#xD;
&#xD;
          -  Any neuromuscular disorders&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Implanted pacemaker&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maryam Shabbir, M.Phil</last_name>
    <role>Principal Investigator</role>
    <affiliation>Riphah International University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Riphah IU</name>
      <address>
        <city>Lahore</city>
        <zip>54000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <reference>
    <citation>Calis M, Demir H, Ulker S, Kirnap M, Duygulu F, Calis HT. Is intraarticular sodium hyaluronate injection an alternative treatment in patients with adhesive capsulitis? Rheumatol Int. 2006 Apr;26(6):536-40. Epub 2005 Aug 10.</citation>
    <PMID>16091920</PMID>
  </reference>
  <reference>
    <citation>Hussein AZ, Donatelli RA. The efficacy of radial extracorporeal shockwave therapy in shoulder adhesive capsulitis: a prospective, randomised, double-blind, placebo-controlled, clinical study. European Journal of Physiotherapy. 2015;18(1):63-76.</citation>
  </reference>
  <reference>
    <citation>Massoud SN, Pearse EO, Levy O, Copeland SA. Operative management of the frozen shoulder in patients with diabetes. J Shoulder Elbow Surg. 2002 Nov-Dec;11(6):609-13.</citation>
    <PMID>12469088</PMID>
  </reference>
  <reference>
    <citation>Wohlgethan JR. Frozen shoulder in hyperthyroidism. Arthritis Rheum. 1987 Aug;30(8):936-9.</citation>
    <PMID>3498494</PMID>
  </reference>
  <reference>
    <citation>Lee S, Lee S, Jeong M, Oh H, Lee K. The effects of extracorporeal shock wave therapy on pain and range of motion in patients with adhesive capsulitis. J Phys Ther Sci. 2017 Nov;29(11):1907-1909. doi: 10.1589/jpts.29.1907. Epub 2017 Nov 24.</citation>
    <PMID>29200621</PMID>
  </reference>
  <reference>
    <citation>Santoboni F, Balducci S, D'Errico V, Haxhi J, Vetrano M, Piccinini G, Ferretti A, Pugliese G, Vulpiani MC. Extracorporeal Shockwave Therapy Improves Functional Outcomes of Adhesive Capsulitis of the Shoulder in Patients With Diabetes. Diabetes Care. 2017 Feb;40(2):e12-e13. doi: 10.2337/dc16-2063. Epub 2016 Nov 29.</citation>
    <PMID>27899492</PMID>
  </reference>
  <reference>
    <citation>Chen CY, Hu CC, Weng PW, Huang YM, Chiang CJ, Chen CH, Tsuang YH, Yang RS, Sun JS, Cheng CK. Extracorporeal shockwave therapy improves short-term functional outcomes of shoulder adhesive capsulitis. J Shoulder Elbow Surg. 2014 Dec;23(12):1843-1851. doi: 10.1016/j.jse.2014.08.010.</citation>
    <PMID>25441567</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 25, 2020</study_first_submitted>
  <study_first_submitted_qc>October 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bursitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

